who should not take glp 1 medications Chart: in 8 Americans Now Use GLP-1 Drugs for Weight Loss Thinking of starting Ozempic, Wegovy,

However, they require careful medical supervision and monitoring

A.GeorgeD

however, human data to date do not show an elevated cancer risk

According to the Summary of Product Characteristics (SmPC) for these medications, headache is classified as very common (affecting more than 1 in 10 people) with weight-management doses of GLP-1 receptor agonists such as Wegovy (semaglutide 2.4 mg) and Saxenda (liraglutide 3 mg)

widely used off-label for weight loss Mounjaro (tirzepatide) FDA-approved for Type 2 diabetes Saxenda (liraglutide) FDA-approved for weight management These shots can cost $900$1,300 per month without insurance